- Home
- THAR vs UPXI Comparison
THAR vs UPXI Comparison
Compare THAR & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THAR
- UPXI
- Stock Information
- Founded
- THAR 2017
- UPXI 2018
- Country
- THAR United States
- UPXI United States
- Employees
- THAR N/A
- UPXI N/A
- Industry
- THAR Biotechnology: Pharmaceutical Preparations
- UPXI Medicinal Chemicals and Botanical Products
- Sector
- THAR Health Care
- UPXI Health Care
- Exchange
- THAR Nasdaq
- UPXI Nasdaq
- Market Cap
- THAR 4.0M
- UPXI 3.9M
- IPO Year
- THAR 2022
- UPXI 2021
- Fundamental
- Price
- THAR $2.03
- UPXI $3.46
- Analyst Decision
- THAR Strong Buy
- UPXI Hold
- Analyst Count
- THAR 1
- UPXI 1
- Target Price
- THAR $17.00
- UPXI $25.00
- AVG Volume (30 Days)
- THAR 47.8K
- UPXI 50.7K
- Earning Date
- THAR 11-07-2024
- UPXI 02-12-2025
- Dividend Yield
- THAR N/A
- UPXI N/A
- EPS Growth
- THAR N/A
- UPXI N/A
- EPS
- THAR N/A
- UPXI N/A
- Revenue
- THAR N/A
- UPXI $22,082,477.00
- Revenue This Year
- THAR N/A
- UPXI $299.03
- Revenue Next Year
- THAR N/A
- UPXI N/A
- P/E Ratio
- THAR N/A
- UPXI N/A
- Revenue Growth
- THAR N/A
- UPXI N/A
- 52 Week Low
- THAR $1.84
- UPXI $2.17
- 52 Week High
- THAR $7.71
- UPXI $33.00
- Technical
- Relative Strength Index (RSI)
- THAR 45.25
- UPXI 39.66
- Support Level
- THAR $1.86
- UPXI $3.31
- Resistance Level
- THAR $2.06
- UPXI $4.10
- Average True Range (ATR)
- THAR 0.11
- UPXI 0.41
- MACD
- THAR -0.00
- UPXI -0.04
- Stochastic Oscillator
- THAR 38.64
- UPXI 9.38
About THAR Tharimmune Inc.
Tharimmune Inc is a biotechnology company developing a portfolio of therapeutic candidates for rare immune, inflammatory, and oncologic diseases. The Company is progressing towards acquiring a clinical-stage asset, known to suppress chronic, debilitating pruritis or uncontrollable itching in primary biliary cholangitis (PBC), a rare orphan liver disease with no known cure. The Company's early-stage immuno-oncology pipeline includes novel multi-specific antibodies targeting epitopes with novel mechanisms of action against validated targets in multiple solid tumors.
About UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products. It reaches consumers through its direct-to-consumer network, wholesale partnerships, and prominent third-party platforms like Amazon.